| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.17 | 5e-06 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0004 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0005 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.0007 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0009 |
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | 0.62 | 0.002 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.15 | 0.003 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |